For patients with IBD and EIMs, TNF antagonists tend to be preferred by gastroenterologists, and the ECCO guidelines recommend the use of TNF antagonists for patients with CD with various EIMs [68]. The gene discussed is TNF; the disease is inflammatory bowel disease.